SPECIAL NOTICE
65 -- Notice of Intent to Sole Source Relenza� (zanamivir)
- Notice Date
- 3/26/2021 12:52:04 PM
- Notice Type
- Special Notice
- Contracting Office
- DEPT OPS ACQ DIV WASHINGTON DC 20528 USA
- ZIP Code
- 20528
- Response Due
- 4/9/2021 2:00:00 PM
- Archive Date
- 04/24/2021
- Point of Contact
- Bridget Boyle, Tanya Hill
- E-Mail Address
-
Bridget.Boyle@hq.dhs.gov, Tanya.Hill@hq.dhs.gov
(Bridget.Boyle@hq.dhs.gov, Tanya.Hill@hq.dhs.gov)
- Description
- In accordance with Federal Acquisition Regulations (FAR) 5.201, the U.S. Department of Homeland Security (DHS), Office of Procurement Operations (OPO) on behalf of the Office of the Chief Human Capital Officer (OCHCO) hereby issues this notice of intent to award a sole source procurement.� DHS OPO intends to solicit and award a sole source Purchase Order to the GlaxoSmithKline, LLC. 5 Moore Drive, Research Triangle Park, Durham, NC 27709 for antiviral medication Relenza� (zanamivir)� This Notice of Intent to Sole Source is issued for the purpose of notifying industry of the Department of Homeland Security�s (DHS) intent to award a sole source Purchase Order under the authority of Federal Acquisition Regulation (FAR) 13.106-1(b) Soliciting from a single source and (FAR) Subpart 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. �Relenza is the only antiviral that is an inhalant and is used when a virus is resistant to Tamiflu or if a person cannot take pills.� The acquisition procedure will be in accordance with FAR Part 12, Acquisition of Commercial Items, and FAR Part 13, Simplified Acquisition Procedures. The anticipated period of performance for this effort will be for one 12-month base period and two 12-month option periods. This is a notice of the intent to award a sole source purchase order. It is published for informational purposes only and not a request for competitive proposals. Therefore, no solicitation document exists for this requirement. No responses to the notice of intent to sole source are anticipated. �However, any firm believing that they can fulfill the requirement may be considered by the agency. Interested parties may identify their interest and capabilities in response to this synopsis. This is NOT a request for quotation or proposals. � All responsible sources that feel they should be considered qualified to provide the foregoing services may submit their interest and capabilities to this notice by 5:00 PM (EST) on April 9, 2021 to Contract Specialist, Bridget Boyle at Bridget.Boyle@hq.dhs.gov and Contracting Officer, Tanya M. Hill at Tanya.Hill@hq.dhs.gov. �No questions or inquiries will be accepted by telephone.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/7f24d5f112944c84b27002c9ef562ba4/view)
- Place of Performance
- Address: Washington, DC, USA
- Country: USA
- Country: USA
- Record
- SN05954406-F 20210328/210326230109 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |